Product Code: BHD0692SD
“Global Radiation Dose Management Market to Reach $586.7 Million by 2032.”
Industry Overview
The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022-2032. The growth in the global radiation dose management market is expected to be driven by the rising prevalence of chronic disorders requiring diagnostic intervention, the growing focus on interventional radiology (IR), and the growing awareness surrounding patient safety and the harmful and biological effects of overexposure to ionizing radiation.
Market Lifecycle Stage
The radiation dose management market is in the developing phase. The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players.
Impact of COVID-19
The decline in imaging volumes during the COVID-19 pandemic impacted the utilization of radiation diagnostic equipment. All radiology equipment had to be thoroughly disinfected using ethanol owing to the strict protocols to minimize the risk of transmission of COVID-19.
In the post-COVID-19 scenario, imaging volumes are expected to return gradually to pre-pandemic levels. As the severity of the COVID-19 pandemic declines, hospitals are expected to reallocate resources toward radiology and pursue diagnostic imaging with renewed vigor. Moreover, in the long term, radiology practices could be permanently redesigned as radiologists become more comfortable treating patients remotely. Furthermore, hospitals and other healthcare institutions are expected to be better equipped to deal with unprecedented events that may disrupt their businesses.
The COVID-19 pandemic placed high importance on automating tasks requiring manual intervention. While conventionally, data transfer and dose recording were done manually, the advent of advanced dose management software (DMS) has enabled automated data transfer from imaging systems into the DMS as well as automated dose recording. This helps eliminate human error and reduces the need for human intervention, which was a concept that gained momentum as a result of the COVID-19 pandemic.
Market Segmentation:
Segmentation 1: by Modality
- CT Scanners
- X-Ray, CR, and DR
- Mammography Systems
- Interventional Angiography Systems/Angio CT
- Fluoroscopy Systems
- PET Scanners and SPECT
- Hybrid Imaging
The global radiation dose management market (by modality) was dominated by the CT scanners segment in 2021, and the trend is expected to continue till the end of the forecast period 2022-2032.
Segmentation 2: by Product
- Radimetrics Enterprise Platform
- DoseWatch and DoseWatch Explore
- teamplay Dose
- NEXO [DOSE]
- tqm/Dose and DoseMonitor
- Radiation Dose Monitor
- Imalogix Platform
- Syncro-Dose
- NovaDose
- DoseWise Portal
- SafeCT
- MyXrayDose
- DoseM
- Dose Tracking System
- DoseTrack
The global radiation dose management market (by product) is dominated by the Radimetrics Enterprise Platform, followed by DoseWatch.
Segmentation 3: by Mode of Deployment
- Web-Based
- On-Premise
- Cloud-Based
The global radiation dose management market (by mode of deployment) is dominated by the web-based segment.
Segmentation 4: by End User
- Hospitals
- Diagnostic Centers
- Others
The global radiation dose management market (by end user) is dominated by the hospitals segment.
Segmentation 5: by Region
- North America - U.S. and Canada
- Europe - Germany, France, U.K., Italy, Spain, Netherlands, and Rest-of-Europe
- Asia-Pacific - Japan, China, India, Australia and New Zealand, South Korea, and Rest-of-Asia-Pacific
- Latin America - Brazil, Mexico, and Rest-of-Latin America
North America held the largest share of 43.71% in 2022, followed by Europe at 24.45%. Additionally, Asia-Pacific is anticipated to grow considerably at high growth, registering a CAGR of 11.83%, respectively, during the forecast period 2022-2032.
Recent Developments in the Global Radiation Dose Management Market
- In December 2020, Bayer AG launched Radimetrics v3.0, the latest evolution of its enterprise dose management utility.
- In December 2020, FUJIFILM Holdings Corporation launched the unique SYNAPSE Dose 2.0 to provide a comprehensive system for managing patient radiation exposure across several imaging modalities.
- In January 2020, Agfa HealthCare collaborated with Maasstad Hospital in the Netherlands to support advancements in the consistency and optimization of radiation doses.
- In April 2019, Qaelum NV signed an agreement with TOYO Corporation to distribute its dose monitoring solution, DOSE, in Japan.
- In January 2019, SST Group, Inc. partnered with Intermountain Healthcare to implement a software platform for the Radiation Dose Monitor (RDM). The software platform permits medical professionals to manage, examine, and optimize the dose delivered to a patient during interventional procedures, medical imaging examinations, and image-guided surgery.
- In August 2018, Imalogix launched a newer version of its radiation dose management platform with additional fluoroscopy capabilities. The software solution can automatically calculate the peak skin dose for the patient during a fluoroscopic procedure.
- In August 2018, Guerbet LLC USA, a subsidiary of the Guerbet Group, partnered with Imalogix to decrease inconsistency and advance the quality, safety, and competence of care around radiation dose management, to enable the network health system and member facilities to monitor patient radiation dose on a per-procedure and cumulative basis.
- In March 2018, PACSHealth, LLC launched DoseMonitor, a radiation dose management software for tracking radiation dose absorption.
Demand - Drivers and Limitations
Following are the drivers for the global radiation dose management market:
- Increasing installed bases of radiology equipment and the number of scans lead to a higher risk of radiation exposure, thus creating demand for dose management solutions.
- The increasing prevalence of cardiovascular diseases and growing occupational hazards in cath labs lead to the growing concern surrounding the effects of radiation exposure.
- Growing focus on interventional radiology (IR) is expected to increase demand for IR imaging systems and subsequently lead to a higher risk of radiation exposure.
- Increasing concern related to radiation overexposure is leading to higher adoption of dose management solutions.
- Growing awareness and initiatives for radiation dose management are expected to push the adoption of dose management software.
- Advancements in dose optimization and benchmarking in various countries will encourage healthcare institutions to adopt dose management software.
The market is expected to face some limitations as well due to the following challenges:
- The lack of awareness among the population and the shortage of skilled and trained professionals leading to a steep learning curve hinders the adoption of dose management software.
- The lack of diagnostic reference levels (DRLs) for radiation dose benchmarking in low-income countries causes healthcare institutions to not pursue the adoption of dose management software with vigor.
How can this report add value to an organization?
- Product/Innovation Strategy: The product segment helps the reader understand the different types of radiation dose management software available for use in hospitals and diagnostic centers. Moreover, the study provides the reader with a detailed understanding of the different radiation dose products based on the modalities they are compatible with (CT scanners, X-Ray, CR, and DR, mammography system, interventional angiography systems/angio CT, fluoroscopy systems, PET scanners and SPECT, and hybrid imaging), the modes on which they can be deployed (cloud-based, web-based, and on-premises), and the end users who can adopt such software (hospitals, diagnostic centers, and others).
- Growth/Marketing Strategy: The global radiation dose management market has seen developments by key players operating in the market, such as partnerships, collaborations and business expansions, and new product launches. Partnerships accounted for the maximum number of key developments, i.e., nearly 70.00% of the total developments in the global radiation dose management market.
- Competitive Strategy: Key players in the global radiation dose management market analyzed and profiled in the study involve players that offer radiation dose software. Moreover, a detailed market share analysis of the players operating in the global radiation dose management market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Some of the prominent names established in this market are:
- Agfa-Gevaert Group
- Bracco
- Bayer AG
- Canon Inc.
- FUJIFILM Holdings Corporation
- Guerbet
- General Electric Company
- Imalogix
- Infinitt Healthcare Co., Ltd.
- Koninklijke Philips N.V.
- LANDAUER
|
- Medic Vision Imaging Solutions Ltd.
- Medsquare
- MyXrayDose Ltd.
- Novarad Corporation
- PACSHealth, LLC
- Qaelum NV
- Sectra AB
- SST Group Inc.
- Siemens Healthineers AG
- Virtual Phantoms Inc.
|
Companies that are not a part of the previously mentioned pool have been well represented across different sections of the report (wherever applicable).
Table of Contents
1 Markets
- 1.1 Global Market Outlook
- 1.1.1 Product Definition
- 1.1.2 Inclusion and Exclusion Criteria
- 1.1.3 Key Findings
- 1.1.4 Assumptions and Limitations
- 1.1.5 Global Market Scenario
- 1.1.5.1 Realistic Growth Scenario
- 1.1.5.2 Optimistic Growth Scenario
- 1.1.5.3 Pessimistic/Conservative Growth Scenario
- 1.2 Industry Outlook
- 1.2.1 Market Overview
- 1.2.1.1 Natural Radiation Sources
- 1.2.1.2 Biological Effects of Radiation
- 1.2.1.3 Usage of Radiation in Medical Devices
- 1.2.1.4 Radiation Dose
- 1.2.1.5 Effective Radiation Dose
- 1.2.1.6 Factors Contributing to Unnecessary Radiation Exposure
- 1.2.1.7 Radiation Exposure Trend
- 1.2.2 Key Trends
- 1.2.2.1 Increasing Development of Imaging Modalities with Technologies that Lower Radiation Dose
- 1.2.2.2 Partnerships and Strategic Business Alliances - Key Developments in the Global Radiation Dose Management Market
- 1.2.2.3 Significant Number of Collaborations among Market Players
- 1.2.3 Opportunity Assessment
- 1.2.4 Patent Analysis
- 1.2.4.1 Awaited Technological Developments
- 1.2.4.2 Patent Filing Trend (by Country)
- 1.2.4.3 Patent Filing Trend (by Year)
- 1.2.5 Comparative Analysis
- 1.2.5.1 Key Features of Major Players
- 1.2.5.1.1 Software Comparison
- 1.2.5.1.2 Comparison of Modes of Data Acquisition
- 1.2.5.1.3 Compatible Modality Comparison
- 1.2.6 Market Gap Analysis
- 1.2.7 Case Studies
- 1.2.7.1 Adoption of Infinitt Healthcare's Web-Based Software, DoseM, by Seoul National University Hospital
- 1.2.7.2 Adoption of GE Healthcare's DoseWatch by One of the Largest Diagnostic Imaging Centers in Europe
- 1.2.8 Pricing Analysis
- 1.2.8.1 Manual Dose Data Recording Cost Per Examination
- 1.2.8.2 Radiation Dose Management Software Pricing
- 1.2.8.3 Server Fee
- 1.3 Impact of COVID-19 on the Global Radiation Dose Management Market
- 1.3.1 Pre-COVID-19
- 1.3.1.1 Trend Analysis
- 1.3.1.2 Radiation Diagnostic Examinations Scenario
- 1.3.1.3 Regional Analysis
- 1.3.2 During COVID-19
- 1.3.2.1 Trend Analysis
- 1.3.2.2 Impact on Radiation Diagnostic Examinations
- 1.3.2.3 Regional Analysis
- 1.3.3 Post-COVID-19
- 1.3.3.1 Trend Analysis
- 1.3.3.2 Emerging Opportunities due to COVID-19 in Radiation Dose Management
- 1.3.3.3 Future Perspective
- 1.3.4 Impact of COVID-19 on Key Players
- 1.3.5 Change in Competitive Landscape and Product Demand
- 1.4 Business Dynamics
- 1.4.1 Impact Analysis
- 1.4.2 Business Drivers
- 1.4.2.1 Increasing installed bases of radiology equipment and the number of scans lead to a higher risk of radiation exposure, thus creating demand for dose management solutions.
- 1.4.2.2 Increasing concern related to radiation overexposure is leading to higher adoption of dose management solutions.
- 1.4.2.3 Growing awareness and initiatives for radiation dose management are expected to push the adoption of dose management software.
- 1.4.2.4 Advancements in dose optimization and benchmarking in various countries will encourage healthcare institutions to adopt dose management software.
- 1.4.2.5 Increasing prevalence of cardiovascular diseases and growing occupational hazards in Cath labs lead to growing concern surrounding the effects of radiation exposure.
- 1.4.2.6 Growing focus on interventional radiology (IR) is expected to increase demand for IR imaging systems and subsequently lead to a higher risk of radiation exposure.
- 1.4.3 Business Restraints
- 1.4.3.1 The lack of awareness among the population and the shortage of skilled and trained professionals leading to a steep learning curve hinders the adoption of dose management software.
- 1.4.3.2 The lack of diagnostic reference levels (DRLs) for radiation dose benchmarking in low-income countries causes healthcare institutions to not pursue the adoption of dose management software with vigor.
- 1.4.4 Business Opportunities
- 1.4.4.1 Cloud-based solutions enable easy access and secure sharing of radiation dose data.
- 1.4.4.2 Growing initiatives on radiation dose management for pediatric procedures will enable the development of software solutions catering to dose management in the pediatric population.
2 Global Radiation Dose Management Market (by Modality)
- 2.1 Opportunity Assessment
- 2.2 Growth-Share Matrix
- 2.3 CT Scanners
- 2.4 X-Ray, CR, and DR
- 2.5 Mammography Systems
- 2.6 Interventional Angiography Systems/Angio CT
- 2.7 Fluoroscopy Systems
- 2.8 PET Scanners and SPECT
- 2.9 Hybrid Imaging
3 Global Radiation Dose Management Market (by Product)
- 3.1 Radimetrics Enterprise Platform
- 3.1.1 Key Features
- 3.1.2 Radimetrics Enterprise Platform- Global Market
- 3.1.3 Installed Base
- 3.1.4 Compatible Modalities
- 3.1.5 Competitive Benchmarking
- 3.2 DoseWatch and DoseWatch Explore
- 3.2.1 Key Features
- 3.2.2 DoseWatch and DoseWatch Explore- Global Market
- 3.2.3 Installed Base
- 3.2.4 Compatible Modalities
- 3.2.5 Competitive Benchmarking
- 3.3 teamplay Dose
- 3.3.1 Key Features
- 3.3.2 teamplay Dose- Global Market
- 3.3.3 Installed Base
- 3.3.4 Compatible Modalities
- 3.3.5 Competitive Benchmarking
- 3.4 NEXO [DOSE]
- 3.4.1 Key Features
- 3.4.2 NEXO [DOSE]- Global Market
- 3.4.3 Installed Base
- 3.4.4 Compatible Modalities
- 3.4.5 Competitive Benchmarking
- 3.5 tqm/Dose and DoseMonitor
- 3.5.1 Key Features
- 3.5.2 tqm/Dose and DoseMonitor- Global Market
- 3.5.3 Installed Base
- 3.5.4 Compatible Modalities
- 3.5.5 Competitive Benchmarking
- 3.6 Radiation Dose Monitor
- 3.6.1 Key Features
- 3.6.2 Radiation Dose Monitor- Global Market
- 3.6.3 Installed Base
- 3.6.4 Compatible Modalities
- 3.6.5 Competitive Benchmarking
- 3.7 Imalogix Platform
- 3.7.1 Key Features
- 3.7.2 Imalogix Platform- Global Market
- 3.7.3 Installed Base
- 3.7.4 Compatible Modalities
- 3.7.5 Competitive Benchmarking
- 3.8 Syncro-Dose
- 3.8.1 Key Features
- 3.8.2 Syncro-Dose- Global Market
- 3.8.3 Installed Base
- 3.8.4 Compatible Modalities
- 3.8.5 Competitive Benchmarking
- 3.9 NovaDose
- 3.9.1 Key Features
- 3.9.2 NovaDose- Global Market
- 3.9.3 Installed Base
- 3.9.4 Compatible Modalities
- 3.9.5 Competitive Benchmarking
- 3.1 DoseWise Portal
- 3.10.1 Key Features
- 3.10.2 DoseWise Portal- Global Market
- 3.10.3 Installed Base
- 3.10.4 Compatible Modalities
- 3.10.5 Competitive Benchmarking
- 3.11 SafeCT
- 3.11.1 Key Features
- 3.11.2 SafeCT- Global Market
- 3.11.3 Installed Base
- 3.11.4 Compatible Modalities
- 3.11.5 Competitive Benchmarking
- 3.12 MyXrayDose
- 3.12.1 Key Features
- 3.12.2 MyXrayDose- Global Market
- 3.12.3 Installed Base
- 3.12.4 Compatible Modalities
- 3.12.5 Competitive Benchmarking
- 3.13 DoseM
- 3.13.1 Key Features
- 3.13.2 DoseM- Global Market
- 3.13.3 Installed Base
- 3.13.4 Compatible Modalities
- 3.13.5 Competitive Benchmarking
- 3.14 Dose Tracking System
- 3.14.1 Key Features
- 3.14.2 Dose Tracking System- Global Market
- 3.14.3 Installed Base
- 3.14.4 Compatible Modalities
- 3.14.5 Competitive Benchmarking
- 3.15 DoseTrack
- 3.15.1 Key Features
- 3.15.2 DoseTrack- Global Market
- 3.15.3 Installed Base
- 3.15.4 Compatible Modalities
- 3.15.5 Competitive Benchmarking
4 Global Radiation Dose Management Market (by Mode of Deployment)
- 4.1 Opportunity Assessment
- 4.2 Growth-Share Matrix
- 4.3 Web-Based
- 4.4 On-Premise
- 4.5 Cloud-Based
5 Global Radiation Dose Management Market (by End User)
- 5.1 Opportunity Assessment
- 5.2 Growth-Share Matrix
- 5.3 Hospitals
- 5.4 Diagnostic Centers
- 5.5 Others
6 Global Radiation Dose Management Market (by Region)
- 6.1 North America Radiation Dose Management Market
- 6.1.1 Regulatory Framework
- 6.1.2 Key Findings and Opportunity Assessment
- 6.1.3 Market Dynamics
- 6.1.4 Market Sizing and Forecast
- 6.1.4.1 North America Radiation Dose Management Market (by Modality)
- 6.1.4.2 North America Radiation Dose Management Market (by End User)
- 6.1.4.3 North America Radiation Dose Management Market (by Mode of Deployment)
- 6.1.4.4 North America Radiation Dose Management Market (by Country)
- 6.1.4.4.1 U.S.
- 6.1.4.4.1.1 Market Dynamics
- 6.1.4.4.1.2 Market Size and Forecast
- 6.1.4.4.1.2.1 U.S. Radiation Dose Management Market (by End User)
- 6.1.4.4.2 Canada
- 6.1.4.4.2.1 Market Dynamics
- 6.1.4.4.2.2 Market Size and Forecast
- 6.1.4.4.2.2.1 Canada Radiation Dose Management Market (by End User)
- 6.2 Europe Radiation Dose Management Market
- 6.2.1 Regulatory Framework
- 6.2.2 Key Findings and Opportunity Assessment
- 6.2.3 Market Dynamics
- 6.2.4 Market Sizing and Forecast
- 6.2.4.1 Europe Radiation Dose Management Market (by Modality)
- 6.2.4.2 Europe Radiation Dose Management Market (by End User)
- 6.2.4.3 Europe Radiation Dose Management Market (by Mode of Deployment)
- 6.2.4.4 Europe Radiation Dose Management Market (by Country)
- 6.2.4.4.1 Germany
- 6.2.4.4.1.1 Market Dynamics
- 6.2.4.4.1.2 Market Sizing and Forecast
- 6.2.4.4.1.2.1 Germany Radiation Dose Management Market (by End User)
- 6.2.4.4.2 France
- 6.2.4.4.2.1 Market Dynamics
- 6.2.4.4.2.2 Market Size and Forecast
- 6.2.4.4.2.2.1 France Radiation Dose Management Market (by End User)
- 6.2.4.4.3 Italy
- 6.2.4.4.3.1 Market Dynamics
- 6.2.4.4.3.2 Market Size and Forecast
- 6.2.4.4.3.2.1 Italy Radiation Dose Management Market (by End User)
- 6.2.4.4.4 U.K.
- 6.2.4.4.4.1 Market Dynamics
- 6.2.4.4.4.2 Market Size and Forecast
- 6.2.4.4.4.2.1 U.K. Radiation Dose Management Market (by End User)
- 6.2.4.4.5 Spain
- 6.2.4.4.5.1 Market Dynamics
- 6.2.4.4.5.2 Market Size and Forecast
- 6.2.4.4.5.2.1 Spain Radiation Dose Management Market (by End User)
- 6.2.4.4.6 Netherlands
- 6.2.4.4.6.1 Market Dynamics
- 6.2.4.4.6.2 Market Size and Forecast
- 6.2.4.4.6.2.1 Netherlands Radiation Dose Management Market (by End User)
- 6.2.4.4.7 Rest-of-Europe
- 6.2.4.4.7.1 Market Dynamics
- 6.2.4.4.7.2 Market Size and Forecast
- 6.2.4.4.7.2.1 Rest-of-Europe Radiation Dose Management Market (by End User)
- 6.3 Asia-Pacific Radiation Dose Management Market
- 6.3.1 Regulatory Framework
- 6.3.2 Key Findings and Opportunity Assessment
- 6.3.3 Market Dynamics
- 6.3.4 Market Size and Forecast
- 6.3.4.1 Asia-Pacific Radiation Dose Management Market (by Modality)
- 6.3.4.2 Asia-Pacific Radiation Dose Management Market (by End User)
- 6.3.4.3 Asia-Pacific Radiation Dose Management Market (by Mode of Deployment)
- 6.3.4.4 Asia-Pacific Radiation Dose Management Market (by Country)
- 6.3.4.4.1 Japan
- 6.3.4.4.1.1 Market Dynamics
- 6.3.4.4.1.2 Market Size and Forecast
- 6.3.4.4.1.2.1 Japan Radiation Dose Management Market (by End User)
- 6.3.4.4.2 China
- 6.3.4.4.2.1 Market Dynamics
- 6.3.4.4.2.2 Market Size and Forecast
- 6.3.4.4.2.2.1 China Radiation Dose Management Market (by End User)
- 6.3.4.4.3 Australia and New Zealand
- 6.3.4.4.3.1 Market Dynamics
- 6.3.4.4.3.2 Market Size and Forecast
- 6.3.4.4.3.2.1 Australia and New Zealand Radiation Dose Management Market (by End User)
- 6.3.4.4.4 South Korea
- 6.3.4.4.4.1 Market Dynamics
- 6.3.4.4.4.2 Market Size and Forecast
- 6.3.4.4.4.2.1 South Korea Radiation Dose Management Market (by End User)
- 6.3.4.4.5 India
- 6.3.4.4.5.1 Market Dynamics
- 6.3.4.4.5.2 Market Size and Forecast
- 6.3.4.4.5.2.1 India Radiation Dose Management Market (by End User)
- 6.3.4.4.6 Rest-of-Asia-Pacific
- 6.3.4.4.6.1 Market Dynamics
- 6.3.4.4.6.2 Market Size and Forecast
- 6.3.4.4.6.2.1 Rest-of-Asia-Pacific Radiation Dose Management Market (by End User)
- 6.4 Latin America Radiation Dose Management Market
- 6.4.1 Regulatory Framework
- 6.4.2 Key Findings and Opportunity Assessment
- 6.4.3 Market Dynamics
- 6.4.4 Market Size and Forecast
- 6.4.4.1 Latin America Radiation Dose Management Market (by Modality)
- 6.4.4.2 Latin America Radiation Dose Management Market (by End User)
- 6.4.4.3 Latin America Radiation Dose Management Market (by Mode of Deployment)
- 6.4.4.4 Latin America Radiation Dose Management Market (by Country)
- 6.4.4.4.1 Brazil
- 6.4.4.4.1.1 Market Dynamics
- 6.4.4.4.1.2 Market Size and Forecast
- 6.4.4.4.1.2.1 Brazil Radiation Dose Management Market (by End User)
- 6.4.4.4.2 Mexico
- 6.4.4.4.2.1 Market Dynamics
- 6.4.4.4.2.2 Market Size and Forecast
- 6.4.4.4.2.2.1 Mexico Radiation Dose Management Market (by End User)
- 6.4.4.4.3 Rest-of-Latin America
- 6.4.4.4.3.1 Market Dynamics
- 6.4.4.4.3.2 Market Size and Forecast
- 6.4.4.4.3.2.1 Rest-of-Latin America Radiation Dose Management Market (by End User)
- 6.5 Middle East and Africa Radiation Dose Management Market
- 6.5.1 Regulatory Framework
- 6.5.2 Key Findings and Opportunity Assessment
- 6.5.3 Market Dynamics
- 6.5.4 Market Size and Forecast
- 6.5.4.1 Middle East and Africa Radiation Dose Management Market (by Modality)
- 6.5.4.2 Middle East and Africa Radiation Dose Management Market (by End User)
- 6.5.4.3 Middle East and Africa Radiation Dose Management Market (by Mode of Deployment)
- 6.5.4.4 Middle East and Africa Radiation Dose Management Market (by Country)
- 6.5.4.4.1 Middle East
- 6.5.4.4.1.1 Market Dynamics
- 6.5.4.4.1.2 Market Size and Forecast
- 6.5.4.4.1.2.1 Middle East Radiation Dose Management Market (by End User)
- 6.5.4.4.2 Africa
- 6.5.4.4.2.1.1 Market Dynamics
- 6.5.4.4.2.2 Market Size and Forecast
- 6.5.4.4.2.2.1 Africa Radiation Dose Management Market (by End User)
7 Market - Competitive Benchmarking and Company Profiles
- 7.1 Competitive Benchmarking and Company Profiles
- 7.1.1 Key Strategies and Developments
- 7.1.1.1 New Offerings
- 7.1.1.2 Partnerships, Alliances, and Business Expansions
- 7.1.1.3 Regulatory and Legal Activities
- 7.2 Company Share Analysis
- 7.3 Company Profiles
- 7.3.1 Agfa-Gevaert Group
- 7.3.1.1 Company Overview
- 7.3.1.2 Role of Agfa-Gevaert Group in the Global Radiation Dose Management Market
- 7.3.1.3 Financials
- 7.3.1.4 Recent Development
- 7.3.1.5 Regional Perspective
- 7.3.1.6 Analyst Perception
- 7.3.2 Bracco
- 7.3.2.1 Company Overview
- 7.3.2.2 Role of Bracco in the Global Radiation Dose Management Market
- 7.3.2.3 Recent Development
- 7.3.2.4 Regional Perspective
- 7.3.2.5 Analyst Perception
- 7.3.3 Bayer AG
- 7.3.3.1 Company Overview
- 7.3.3.2 Role of Bayer AG in the Global Radiation Dose Management Market
- 7.3.3.3 Financials
- 7.3.3.4 Recent Development
- 7.3.3.5 Regional Perspective
- 7.3.3.6 Analyst Perception
- 7.3.4 Canon Inc.
- 7.3.4.1 Company Overview
- 7.3.4.2 Role of Canon Inc. in the Global Radiation Dose Management Market
- 7.3.4.3 Financials
- 7.3.4.4 Regional Perspective
- 7.3.4.5 Analyst Perception
- 7.3.5 FUJIFILM Holdings Corporation
- 7.3.5.1 Company Overview
- 7.3.5.2 Role of FUJIFILM Holdings Corporation in the Global Radiation Dose Management Market
- 7.3.5.3 Financials
- 7.3.5.4 Recent Development
- 7.3.5.5 Regional Perspective
- 7.3.5.6 Analyst Perception
- 7.3.6 Guerbet
- 7.3.6.1 Company Overview
- 7.3.6.2 Role of Guerbet in the Global Radiation Dose Management Market
- 7.3.6.3 Financials
- 7.3.6.4 Recent Development
- 7.3.6.5 Regional Perspective
- 7.3.6.6 Analyst Perception
- 7.3.7 General Electric Company
- 7.3.7.1 Company Overview
- 7.3.7.2 Role of General Electric Company in the Global Radiation Dose Management Market
- 7.3.7.3 Financials
- 7.3.7.4 Regional Perspective
- 7.3.7.5 Analyst Perception
- 7.3.8 Imalogix
- 7.3.8.1 Company Overview
- 7.3.8.2 Role of Imalogix in the Global Radiation Dose Management Market
- 7.3.8.3 Recent Development
- 7.3.8.4 Regional Perspective
- 7.3.8.5 Analyst Perception
- 7.3.9 Infinitt Healthcare Co., Ltd.
- 7.3.9.1 Company Overview
- 7.3.9.2 Role of Infinitt Healthcare Co., Ltd. in the Global Radiation Dose Management Market
- 7.3.9.3 Regional Perspective
- 7.3.9.4 Analyst Perception
- 7.3.10 Koninklijke Philips N.V.
- 7.3.10.1 Company Overview
- 7.3.10.2 Role of Koninklijke Philips N.V. in the Global Radiation Dose Management Market
- 7.3.10.3 Financials
- 7.3.10.4 Regional Perspective
- 7.3.10.5 Analyst Perception
- 7.3.11 LANDAUER
- 7.3.11.1 Company Overview
- 7.3.11.2 Role of LANDAUER in the Global Radiation Dose Management Market
- 7.3.11.3 Regional Perspective
- 7.3.11.4 Analyst Perception
- 7.3.12 Medic Vision Imaging Solutions Ltd.
- 7.3.12.1 Company Overview
- 7.3.12.2 Role of Medic Vision Imaging Solutions Ltd. in the Global Radiation Dose Management Market
- 7.3.12.3 Regional Perspective
- 7.3.12.4 Analyst Perception
- 7.3.13 Medsquare
- 7.3.13.1 Company Overview
- 7.3.13.2 Role of Medsquare in the Global Radiation Dose Management Market
- 7.3.13.3 Recent Development
- 7.3.13.4 Regional Perspective
- 7.3.13.5 Analyst Perception
- 7.3.14 MyXrayDose Ltd.
- 7.3.14.1 Company Overview
- 7.3.14.2 Role of MyXrayDose Ltd. in the Global Radiation Dose Management Market
- 7.3.14.3 Analyst Perception
- 7.3.15 Novarad Corporation
- 7.3.15.1 Company Overview
- 7.3.15.2 Role of Novarad Corporation in the Global Radiation Dose Management Market
- 7.3.15.3 Regional Perspective
- 7.3.15.4 Analyst Perception
- 7.3.16 PACSHealth, LLC
- 7.3.16.1 Company Overview
- 7.3.16.2 Role of PACSHealth, LLC in the Global Radiation Dose Management Market
- 7.3.16.3 Recent Development
- 7.3.16.4 Regional Perspective
- 7.3.16.5 Analyst Perception
- 7.3.17 Qaelum NV
- 7.3.17.1 Company Overview
- 7.3.17.2 Role of Qaelum NV in the Global Radiation Dose Management Market
- 7.3.17.3 Recent Development
- 7.3.17.4 Regional Perspective
- 7.3.17.5 Analyst Perception
- 7.3.18 Sectra AB
- 7.3.18.1 Company Overview
- 7.3.18.2 Role of Sectra AB in the Global Radiation Dose Management Market
- 7.3.18.3 Financials
- 7.3.18.4 Recent Development
- 7.3.18.5 Regional Perspective
- 7.3.18.6 Analyst Perception
- 7.3.19 SST Group Inc.
- 7.3.19.1 Company Overview
- 7.3.19.2 Role of SST Group Inc. in the Global Radiation Dose Management Market
- 7.3.19.3 Recent Development
- 7.3.19.4 Regional Perspective
- 7.3.19.5 Analyst Perception
- 7.3.20 Siemens Healthineers AG
- 7.3.20.1 Company Overview
- 7.3.20.2 Role of Siemens Healthineers AG in the Global Radiation Dose Management Market
- 7.3.20.3 Financials
- 7.3.20.4 Regional Perspective
- 7.3.20.5 Analyst Perception
- 7.3.21 Virtual Phantoms Inc.
- 7.3.21.1 Company Overview
- 7.3.21.2 Role of Virtual Phantoms Inc. in the Global Radiation Dose Management Market
- 7.3.21.3 Key Developments
- 7.3.21.4 Regional Perspective
- 7.3.21.5 Analyst Perception